AKT1 and breast cancer: This dual-action approach achieves over 90% tumor growth inhibition in murine breast cancer models by combining NIR-triggered thermal ablation with RSV-mediated suppression of pro-survival pathways like NF-κB and PI3K/Akt [127, 128].